#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Oesophageal squamous cell carcinoma stage III Pelizaeus-Merzbacher disease Prophylaxis against transplant rejection Myotonic dystrophy Lip and/or oral cavity cancer Paraganglion neoplasm Alpha-1 antitrypsin deficiency Plasma cell myeloma refractory Splenic marginal zone lymphoma Crigler-Najjar syndrome Vaginal cancer Small intestine adenocarcinoma Systemic mastocytosis Hodgkin's disease recurrent Ocular lymphoma More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia Encephalitis autoimmune – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) Cytokine release syndrome – Treatment Leiomyosarcoma metastatic – Basic Information Waldenstrom’s macroglobulinaemia – Trials in Disease Andersen-Tawil syndrome – Diagnostics Cholangitis sclerosing – Treatment Advanced systemic mastocytosis – Treatment Metachromatic leukodystrophy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    PIPOTIAZINE Pegaspargase Lidocaine Perindopril Tert-Butylamine Cpk850 Suvecaltamide Divarasib Artemisia Vulgaris Valproic Acid Levoleucovorin Disodium Lovastatin Resiquimod Sulfate Pseudoephedrine Hydrochloride ATIGOTATUG Axicabtagene Ciloleucel Bms-986408 Peppermint Oil Filgotinib Ibrexafungerp FG001 More therapies…

    Learn about Your Condition

    Psoriatic arthropathy Retinopathy proliferative Cognitive disorder Renal disorder C3 glomerulopathy Sepsis Injection site pain Combined immunodeficiency Femur fracture Pigmentary glaucoma Naevoid melanoma Intermittent claudication Actinic cheilitis Haemorrhage intracranial Corneal graft rejection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Renal transplant

  • A Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Felzartamab
    • Sodium Chloride
    Austria Czechia France Germany Spain

  • Study of immunosuppression reduction in kidney transplant patients with septic shock or respiratory failure receiving drug combination therapy in intensive care

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Azathioprine
    • Ciclosporin
    • Everolimus
    France

  • Study on Preventing CMV Infection in Low-Risk Kidney Transplant Patients Using Ganciclovir and Valganciclovir

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ganciclovir
    • Valganciclovir Hydrochloride
    Spain

  • Study of Belatacept versus Tacrolimus in Kidney Transplant Recipients with Subclinical Antibody Mediated Rejection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Belatacept
    • Tacrolimus
    France

  • Study on the Safety and Effectiveness of Dapagliflozin for Kidney Function in Non-Diabetic Kidney Transplant Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Dapagliflozin
    Denmark

  • Study of Ravulizumab to Prevent Delayed Graft Function in Adult Patients After Kidney Transplant

    Recruiting

    3 1 1
    Investigated Diseases:
    • Delayed graft function
    • Renal transplant
    Investigated Drugs:
    • Ravulizumab
    Austria Czechia France Germany Italy Poland +2
1 2 3 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!